Jeff Zygouras
Directeur Financier/CFO chez NEUPATH HEALTH INC.
Fortune : 4 972 $ au 30/04/2024
Postes actifs de Jeff Zygouras
Sociétés | Poste | Début | Fin |
---|---|---|---|
NEUPATH HEALTH INC. | Secrétaire Général | 17/03/2022 | - |
Directeur Financier/CFO | 30/06/2021 | - | |
Comptroller/Controller/Auditor | 01/01/2019 | 30/06/2021 |
Historique de carrière de Jeff Zygouras
Anciens postes connus de Jeff Zygouras
Sociétés | Poste | Début | Fin |
---|---|---|---|
NUVO PHARMACEUTICALS INC. | Corporate Officer/Principal | 01/09/2018 | 01/06/2019 |
CRESCITA THERAPEUTICS INC. | Corporate Officer/Principal | 01/03/2016 | 01/06/2017 |
Ernst & Young, Inc.
Ernst & Young, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young, Inc. is a professional services firm based in Toronto, Canada. The Canadian company provides a range of services and solutions to help clients transform, grow, and operate. The company's services include strategy consulting, analytics consulting, people advisory services, transactions and corporate finance, assurance, tax planning, and legal services. The company also offers advanced technology, audit technology, tax technology, and managed services. Ernst & Young is committed to creating long-term value for all stakeholders and building a better working world. The CEO of the company is Jad Shimaly. | Corporate Officer/Principal | - | - |
Formation de Jeff Zygouras
University of Toronto | Graduate Degree |
Statistiques
Internationale
Canada | 6 |
Opérationnelle
Corporate Officer/Principal | 3 |
Comptroller/Controller/Auditor | 1 |
Director of Finance/CFO | 1 |
Sectorielle
Health Technology | 3 |
Finance | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
NEUPATH HEALTH INC. | Finance |
CRESCITA THERAPEUTICS INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Nuvo Pharmaceuticals, Inc.
Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
Ernst & Young, Inc.
Ernst & Young, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young, Inc. is a professional services firm based in Toronto, Canada. The Canadian company provides a range of services and solutions to help clients transform, grow, and operate. The company's services include strategy consulting, analytics consulting, people advisory services, transactions and corporate finance, assurance, tax planning, and legal services. The company also offers advanced technology, audit technology, tax technology, and managed services. Ernst & Young is committed to creating long-term value for all stakeholders and building a better working world. The CEO of the company is Jad Shimaly. | Commercial Services |
- Bourse
- Insiders
- Jeff Zygouras
- Expérience